Trusopt and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trusopt (dorzolamide hydrochloride) and Fenofibrate (fenofibrate). Common drug interactions include fall among females and eye irritation among males.

The phase IV clinical study analyzes what interactions people have when they take Trusopt and Fenofibrate. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Trusopt?

Trusopt has active ingredients of dorzolamide hydrochloride. It is often used in glaucoma. eHealthMe is studying from 3,165 Trusopt users. Check the latest studies of Trusopt.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

On Jul, 27, 2026

12 people who take Trusopt and Fenofibrate together, and have interactions are studied.

Trusopt and Fenofibrate drug interactions.

What are the common drug interactions of Trusopt and Fenofibrate, by gender? *:

female:

Fall
Infusion site erythema (reddening of the skin at infusion site)
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Anaemia (lack of blood)
Arthralgia (joint pain)
Cold sweat
Effusion (an escape of fluid into a body cavity)
Epistaxis (bleed from the nose)
Fatigue (feeling of tiredness)
Haematoma (collection of blood outside the blood vessels)

male:

Eye irritation
Gallbladder disorder
Pancreatitis (inflammation of pancreas)
Vision blurred
Hallucination (an experience involving the perception of something not present)

What are the common drug interactions of Trusopt and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cellulitis (infection under the skin)
Infusion site reaction
Infusion site swelling
Infusion site urticaria (rash of round, red welts on the skin at infusion site)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Cold sweat
Effusion (an escape of fluid into a body cavity)
Fatigue (feeling of tiredness)

50-59:

n/a

60+:

Eye irritation
Fall
Tooth abscess (pus formation in tooth)
Gallbladder disorder
Pancreatitis (inflammation of pancreas)
Vision blurred
Anaemia (lack of blood)
Arthralgia (joint pain)
Haematoma (collection of blood outside the blood vessels)
Hallucination (an experience involving the perception of something not present)

What are the existing conditions these people have? *

Insomnia (sleeplessness): 3 people, 25.00%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Diabetes: 3 people, 25.00%
Pulmonary Congestion (congestion in the lungs): 2 people, 16.67%
Prostatic Disorder: 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Eye Infection: 2 people, 16.67%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Trusopt and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously